ArticleHead and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings2025
A Coarse-to-Fine Framework for Mid-Radiotherapy Head and Neck Cancer MRI Segmentation.
Article in Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Overview of the Head and Neck Tumor Segmentation for Magnetic Resonance Guided Applications (HNTS-MRG) 2024 Challenge.Head and Neck Tumor Segmentation for MR-Guided Applications : First MICCAI Challenge, HNTS-MRG 2024, held in conjunction with MICCAI 2024, Marrakesh, Morocco, October 17, 2024, proceedings · 2025Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Radiotherapy is the preferred treatment modality for head and neck cancer (HNC). During the treatment, adaptive radiation therapy (ART) technology is commonly employed to account for changes in target volume and alterations in patient anatomy. This adaptability ensures that treatment remains precise and effective despite these physiological variations. Magnetic resonance imaging (MRI) provides higher-resolution soft tissue images, making it valuable in target delineation of HNC treatment. The delineation in ART should adhere to the same principles as those used in the initial delineation. Consequently, the contouring performed on MR images during ART should reference the earlier delineations for consistency and accuracy. To address this, we proposed a coarse-to-fine cascade framework based on 3D U-Net to segment mid-radiotherapy HNC from T2-weighted MRI. The model consists of two interconnected components: a coarse segmentation network and a fine segmentation network, both sharing the same architecture. In the coarse segmentation phase, different forms of prior information were used as input, including dilated pre-radiotherapy masks. In the fine segmentation phase, a resampling operation based on a bounding box focuses on the region of interest, refining the prediction with the mid-radiotherapy image to achieve the final segmentation. In our experiment, the final results were achieved with an aggregated Dice Similarity Coefficient (DSC) of 0.562, indicating that the prior information plays a crucial role in enhancing segmentation accuracy. (Team name: TNL_skd).
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.